Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 2/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.76 |
| ▸ | CA2 | P00918 | 2/20 | 0.71 |
| ▸ | CA12 | O43570 | 1/20 | 0.71 |
| ▸ | CA9 | Q16790 | 1/20 | 0.71 |
| ▸ | AR | P10275 | 1/20 | 0.69 |
| ▸ | DDX3X | O00571 | 1/20 | 0.66 |
| ▸ | CA1 | P00915 | 1/20 | 0.65 |
| ▸ | MMP1 | P03956 | 1/20 | 0.65 |
| ▸ | MMP2 | P08253 | 1/20 | 0.65 |
| ▸ | MMP9 | P14780 | 1/20 | 0.65 |
| ▸ | MMP8 | P22894 | 1/20 | 0.65 |
| ▸ | MMP13 | P45452 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.64 |
| ▸ | MEN1 | O00255 | 3/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL893934 | 0.91 | CA2 (0.71) | PGRALDH1A1CA2CA12CA9 | |
| SCHEMBL5228114 | 0.87 | ALDH1A1 (0.71) | PGRALDH1A1CA2ARDDX3X | |
| SCHEMBL5037028 | 0.87 | ALDH1A1 (0.71) | PGRALDH1A1CA2CA12CA9 | |
| SCHEMBL5233742 | 0.87 | ALDH1A1 (0.71) | PGRALDH1A1CA2ARDDX3X | |
| SCHEMBL15043012 | 0.87 | ALDH1A1 (0.71) | PGRALDH1A1CA2CA12CA9 | |
| SCHEMBL23928394 | 0.87 | ALDH1A1 (0.71) | PGRALDH1A1CA2ARDDX3X | |
| SCHEMBL13970848 | 0.87 | ALDH1A1 (0.71) | PGRALDH1A1CA2ARDDX3X | |
| SCHEMBL95740 | 0.87 | ALDH1A1 (0.71) | PGRALDH1A1CA2CA12CA9 | |
| SCHEMBL15043011 | 0.85 | ALDH1A1 (0.66) | PGRALDH1A1CA2DDX3XCA1 | |
| SCHEMBL8248683 | 0.85 | ALDH1A1 (0.65) | PGRALDH1A1CA2DDX3XCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4551478-A | 3-Nitrobenzene sulfonanilide derivatives and fungicidal compositions for the control of plant diseases containing same | MITSUI TOATSU CHEMICALS, INC. (JP) | 1985-11-05 | — | — | US | claimed |
| US-12427798-B2 | Heat-sensitive recording composition | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2025-09-30 | — | — | US | disclosed |
| EP-3636446-B1 | RECORDING MATERIAL, RECORDING SHEET AND USE OF A COMPOUND AS COLOUR-DEVELOPING AGENT | NIPPON SODA CO (JP) | 2025-04-16 | — | — | EP | disclosed |
| US-20250001788-A1 | HEAT-SENSITIVE RECORDING COMPOSITION | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2025-01-02 | — | — | US | disclosed |
| EP-4442467-A1 | THERMAL RECORDING COMPOSITION | Nippon Kayaku Kabushiki Kaisha (JP) | 2024-10-09 | — | — | EP | disclosed |
| EP-4442468-A1 | HEAT-SENSITIVE RECORDING COMPOSITION | Nippon Kayaku Kabushiki Kaisha (JP) | 2024-10-09 | — | — | EP | disclosed |
| US-20240326501-A1 | HEAT-SENSITIVE RECORDING COMPOSITION | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2024-10-03 | — | — | US | disclosed |
| WO-2023100900-A1 | THERMAL RECORDING COMPOSITION | 日本化薬株式会社 | 2023-06-08 | — | — | WO | disclosed |
| WO-2023100902-A1 | HEAT-SENSITIVE RECORDING COMPOSITION | 日本化薬株式会社 | 2023-06-08 | — | — | WO | disclosed |
| US-11529819-B2 | Recording material and compound | NIPPON SODA CO., LTD. (JP) | 2022-12-20 | — | — | US | disclosed |
| WO-2001028537-A2 | BISSULFONAMIDE DERIVATIVES AS ENZYME INHIBITORS | ARROW THERAPEUTICS LIMITED (GB) | 2001-04-26 | — | — | WO | disclosed |
| EP-0841919-A4 | INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE | MERCK & CO INC (US) | 1999-02-24 | — | — | EP | disclosed |
| EP-0841919-A1 | INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE | Merck & Co., Inc. (US) | 1998-05-20 | — | — | EP | disclosed |
| US-5710171-A | ANTICANCER AND ANTITUMOR AGENTS | MERCK & CO., INC. (US) | 1998-01-20 | — | — | US | disclosed |
| WO-1996037204-A1 | INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE | MERCK & CO., INC. (US) | 1996-11-28 | — | — | WO | disclosed |
| US-4551478-A | 3-Nitrobenzene sulfonanilide derivatives and fungicidal compositions for the control of plant diseases containing same | MITSUI TOATSU CHEMICALS, INC. (JP) | 1985-11-05 | — | — | US | disclosed |
| US-4551478-A | 3-Nitrobenzene sulfonanilide derivatives and fungicidal compositions for the control of plant diseases containing same | MITSUI TOATSU CHEMICALS, INC. (JP) | 1985-11-05 | — | — | US | disclosed |
| US-4551478-A | 3-Nitrobenzene sulfonanilide derivatives and fungicidal compositions for the control of plant diseases containing same | MITSUI TOATSU CHEMICALS, INC. (JP) | 1985-11-05 | — | — | US | disclosed |
| US-4497828-A | 3-Nitro-4-methylbenzene sulfon-2-chloro-4-nitroanilide and fungicidal composition for the control of plant diseases containing same | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1985-02-05 | — | — | US | disclosed |
| US-4289847-A | 2-EQUIVALENT YELLOW COUPLER | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1981-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11529819-B2 | Recording material and compound | H1-0, DOT1L, H1-4 | PGR 2184/4885ALDH1A1 1091/4885CA2 330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.